-
Mashup Score: 0l-carnitine, a friend or foe for cardiovascular disease? A Mendelian randomization study - BMC Medicine - 2 year(s) ago
Background l-carnitine is emerging as an item of interest for cardiovascular disease (CVD) prevention and treatment, but controversy exists. To examine the effectiveness and safety of l-carnitine, we assessed how genetically different levels of l-carnitine are associated with CVD risk and its risk factors. Given higher CVD incidence and l-carnitine in men, we also examined sex-specific…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
Though absolute differences did not emerge in the treatment of hepatic encephalopathy with L-carnitine, a presenter at the Digital International Liver Congress suggested the changes seen indicate more research with higher doses may be warranted.“Twenty-four weeks of L-carnitine supplementation in covert hepatic encephalopathy patients did not improve quality of life,” Eileen Yoon, MD,
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#LCarnitine showed a positive impact on #hepaticencephalopathy both in cognitive function and MELD score, but not overall QOL #ILC2020 https://t.co/0dgdEuyT1K
-
#LCarnitine - a friend for #cardiovascular disease? #MendelianRandomization study incl @stevesphd #CMSchooling @HKUniversity https://t.co/eAVoeqeAkl "Findings do not support a beneficial association of L-carnitine with CVD and its risk factors but suggest potential harm"